Evidence map›Paper›PMID 33148819›Full record

ArticlemSphere2020

Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine Trial.

Florence Bourgeois, Peter Doshi, Kyungwan Hong, Tom Jefferson, Mark Jones, Haeyoung Lee, Anisa Rowhani-Farid, Larissa Shamseer, O'Mareen Spence

Abstract readLetter
In one paragraph

Article in mSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Florence BourgeoisDepartment of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
Peter DoshiDepartment of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland, USA pdoshi@rx.umaryland.edu.
Kyungwan HongDepartment of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
Tom JeffersonCentre for Evidence-Based Medicine, University of Oxford, Oxford, United Kingdom.
Mark JonesInstitute for Evidence-based Healthcare, Bond University, Gold Coast, Queensland, Australia.
Haeyoung LeeDepartment of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
Anisa Rowhani-FaridDepartment of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.ORCID 0000-0003-3637-2423
Larissa ShamseerUniversity of Ottawa, Ottawa, Ontario, Canada.
O'Mareen SpenceDepartment of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
University of Maryland Center of Excellence in Regulatory Science and InnovationU01FD005946 · FDA · UNIV OF MARYLAND, COLLEGE PARK · PI BENTLEY, WILLIAM E., POLLI, JAMES E · 2016 to 2025
$21.5M
FDA HHS U01 FD005946NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clinical Trials as TopicControl GroupsData AccuracyAdjuvants, ImmunologicHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18HumansPapillomavirus InfectionsPlacebosPublic Reporting of Healthcare DataAdjuvants, ImmunologicHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18Placebosdrug regulationdrug safetyevidence-based medicinetransparency

Identifiers

PMID33148819
PMCPMC7643827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.